AF
Antonino Nicolò Fallica
Universitat de Barcelona, Instutute for Bioingeneering of Catalunya, University of Catania
Research areas: Chemistry · Organic Chemistry · Synthesis and biological activity · Heme Oxygenase-1 and Carbon Monoxide · Bioactive Compounds and Antitumor Agents
Employment
-
University of Barcelona Postdoctoral Researcher2026 - Present
-
Instutute for Bioingeneering of Catalunya Postdoctoral Researcher2023 - 2026
-
University of Catania Research fellow2022 - 2023
-
University of Catania Research Fellow2022 - 2022
Education
-
University of Catania PhD in Biotechnology2018 - 2022
-
University of Catania M.S. in Chemistry and Pharmaceutical Technology
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- Modulation of Tau Protein Neurotoxic Hallmarks by Novel σ1R Agonists/HDAC Inhibitor Dual‐Acting Compounds Save
- Development of DNA Aptamers Against Leishmania infantum GP63 Protein for Therapeutic and Diagnostic Applications Save
- Semi-Synthetic H2S Releasing Compounds with Antioxidant and Vasorelaxant Properties Save
- YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates Save
- Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy Save
- Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D Human Breast and Bladder Cancer Cell Lines Save
- Novel Acetamide-Based HO-1 Inhibitor Counteracts Glioblastoma Progression by Interfering with the Hypoxic–Angiogenic Pathway Save
- Synthesis and in Vitro Evaluation of CAPE Derivatives as Ferroptosis Inducers in Triple Negative Breast Cancer Save
- Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills Save
- Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections Save
- Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects Save
- Correction to “Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents” Save
- The Promise of Nanotechnology in Personalized Medicine Save
- From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes Save
- Growing the molecular architecture of imidazole-like ligands in HO-1 complexes Save
- Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity Save
- Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents Save
- The Potential Role of Sildenafil in Cancer Management through EPR Augmentation Save
- Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective Save
- Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation Save